Condition 1: Nausea. Condition 2: vomiting. Nausea Vomiting
Conditions
Interventions
Intervention 1: Intervention group: Aperpitant capsule 80 mg is prescribed one hour before the operation, and at the same time as the anti-nausea drug ondansetron 4 mg is administered intravenously. I
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: patients with ASA health scale of 1 or 2 patients who are candidated for cholecystectomy surgery
Exclusion criteria
Exclusion criteria: patients with ASA health scale of 3, 4 or 5 patients with other anesthesia methods patients with any systemic diseases such as diabetes, asthma, cardiovascular diseases, gastroesophageal reflux, severe obesity, BMI > 30, hepatorenal diseases, neuromuscular diseases, psychiatric illnesses, alcoholic patients, drug abusers, smokers pregnant or lactating patients patients presented with acute cholecystitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of nausea. Timepoint: 6 and 24 hour post-operation. Method of measurement: VAS criteria.;Vomiting. Timepoint: 6 and 24 hour post-operation. Method of measurement: if vomiting happen or not. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasser Malekpour Alamdari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed